论文部分内容阅读
目的观察米非司酮配伍米索前列醇终止瘢痕子宫妊娠的临床效果。方法选择2008年1月至2010年6月在天津市塘沽区妇幼保健院计划生育门诊自愿要求药物流产的瘢痕子宫妊娠者78例为观察组,选择同期非瘢痕子宫妊娠78例为对照组,观察两组流产效果以及流产后出血量。结果两组的流产效果及流产后出血量比较差异无统计学意义(P>0.05),说明米非司酮配伍米索前列醇用于瘢痕子宫早孕与非瘢痕子宫早孕疗效相当。结论药物流产用于瘢痕子宫的早孕(<49 d的妊娠)有效、安全。
Objective To observe the clinical effect of mifepristone and misoprostol in ending uterine scar pregnancy. Methods From January 2008 to June 2010, 78 cases of uterine scar pregnancy were randomly selected from family planning outpatient clinics in Maternal and Child Health Care Hospital of Tanggu District, Tianjin. 78 cases of non-scarring uterine pregnancy were selected as the control group. Two groups of abortion effects and post-abortion bleeding. Results There was no significant difference in abortion outcome and blood loss after abortion between the two groups (P> 0.05), indicating that mifepristone and misoprostol were effective for scarring uterine early pregnancy and non-scarring early pregnancy. Conclusions Medical abortion is effective and safe for the first trimester pregnancy (<49 d of pregnancy) in scarring uterus.